[ 3 / biz / cgl / ck / diy / fa / ic / jp / lit / sci / vr / vt ] [ index / top / reports ] [ become a patron ] [ status ]
2023-11: Warosu is now out of extended maintenance.

/biz/ - Business & Finance

Search:


View post   

>> No.16755460 [View]
File: 1004 KB, 883x1214, 45B8B4E1-834B-45FE-A62C-6B282604F393.jpg [View same] [iqdb] [saucenao] [google]
16755460

>>16755231
I still like MRK and LLY, because cancer and diabetes aren’t going anywhere. But they’ve run up soo far that I’m waiting to add.

I got stopped out of GSK, and I’m still in AZN, but I’m looking to add to those on any Brexit related selloffs.

Potential gains for MRK, GSK, and AZN in China, even from phase one alone. AZN also has partnerships in China that should allow them to thrive.

But China has been encouraging their own oncology and vaccine development, and that could cause a real headwind, so there’s a lot of unknowns.

>>16755291
This doesn’t seem to be an aerospace and defense company. And your language is similar to the AMRN shills...
When did you start with stocks and when did you start with /smg/?

>>16755357
What’re your pharma picks?
For med tech I’ve been considering something like CRL, but it’s not devices.

One caught my eye recently but I can’t find the name anymore, I’ll see if I can dig it up. Maybe VEEV?

Here’s a pic from the Argus New Years investment theses report that might interest you, the med tech section.

Navigation
View posts[+24][+48][+96]